Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma (Q84567412)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 July 2010
edit
Language Label Description Also known as
English
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma
scientific article published on 14 July 2010

    Statements

    title
    Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    20629661
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20629661%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    7 February 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q84567412&oldid=2244163889"